A phase I/II study of COL-3 [incyclinide] administered on a continuous daily oral schedule in patients with recurrent high-grade astrocytoma.

Trial Profile

A phase I/II study of COL-3 [incyclinide] administered on a continuous daily oral schedule in patients with recurrent high-grade astrocytoma.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 20 Jun 2013

At a glance

  • Drugs Incyclinide (Primary)
  • Indications Anaplastic astrocytoma; Glioblastoma; Glioma; Oligodendroglioma
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 20 Jun 2013 Additional lead trial centre added as reported by ClinicalTrials.gov.
    • 09 Nov 2006 Status changed from in progress to completed.
    • 04 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top